Effectiveness of methylprednisolone therapy in patients with a high-risk common type of COVID-19 pneumonia: a retrospective cohort study

The optimal timing of glucocorticoid treatment for coronavirus disease 2019 (COVID-19) pneumonia is uncertain. We evaluated the clinical outcomes of methylprednisolone therapy (MPT) for patients with a high-risk common type (HRCT) COVID-19 pneumonia. We conducted a multicenter retrospective cohort s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lei, Qu, Hang, Li, Jun Jian, Yang, Yan Wei, Zeng, Qiu Xi, Gong, Yan Wen, He, Zhong Zhi, Zhang, Yi He, Zhang, Wei, Liu, Bin, Che, Li Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532093/
https://www.ncbi.nlm.nih.gov/pubmed/34677701
http://dx.doi.org/10.1007/s10238-021-00765-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532093/
https://www.ncbi.nlm.nih.gov/pubmed/34677701
http://dx.doi.org/10.1007/s10238-021-00765-1

Ejemplares similares